Literature DB >> 1995903

Synthesis and protein-tyrosine kinase inhibitory activities of flavonoid analogues.

M Cushman1, D Nagarathnam, D L Burg, R L Geahlen.   

Abstract

Treatment of o-hydroxyacetophenones 2a-e with excess lithium bis(trimethylsilyl)amide followed by dialkyl carbonates gave alkyl 3-(2-hydroxyaryl)-3-oxopropanoates 3a-e. The latter substances were transformed through the reaction of their magnesium chelates with benzoyl chlorides into a series of 3-(alkoxycarbonyl)-2-arylflavones, which were subsequently elaborated into a variety of flavonoids. These compounds were tested for their abilities to inhibit the in vitro protein-tyrosine kinase activity of p56lck, an enzyme which is thought to play a key role in mediating signal transduction from the CD4 receptor during lymphocyte activation. All of the active compounds had either an amino or a hydroxyl substituent at the 4'-position of the 2-aryl ring. The most active substance prepared in this study is compound 17c, which is approximately 1 order of magnitude more potent than the natural product quercetin (1). Compound 17c was a competitive inhibitor of p56lck with respect to ATP and was highly selective for the inhibition of protein-tyrosine over protein-serine/threonine kinases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1995903     DOI: 10.1021/jm00106a047

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

Review 1.  Overview--flavonoids: a new family of benzodiazepine receptor ligands.

Authors:  J H Medina; H Viola; C Wolfman; M Marder; C Wasowski; D Calvo; A C Paladini
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

2.  Regulation of the serine-base exchange enzyme system by CD4: effects of monoclonal antibodies, jacalin, interleukin 16 and the HIV membrane protein gp120.

Authors:  M J Dumaurier; C Pelassy; J P Breittmayer; C Aussel
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

3.  Phytochemicals as Anticancer and Chemopreventive Topoisomerase II Poisons.

Authors:  Adam C Ketron; Neil Osheroff
Journal:  Phytochem Rev       Date:  2014-03-01       Impact factor: 5.374

Review 4.  Cell-signaling targets for antitumour drug development.

Authors:  V G Brunton; P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

5.  Flavones modulate respiratory epithelial innate immunity: Anti-inflammatory effects and activation of the T2R14 receptor.

Authors:  Benjamin M Hariri; Derek B McMahon; Bei Chen; Jenna R Freund; Corrine J Mansfield; Laurel J Doghramji; Nithin D Adappa; James N Palmer; David W Kennedy; Danielle R Reed; Peihua Jiang; Robert J Lee
Journal:  J Biol Chem       Date:  2017-04-03       Impact factor: 5.157

6.  Partial purification and characterization of the lck protein-tyrosine kinase from bovine thymus.

Authors:  Q M Wang; P R Srinivas; M L Harrison; R L Geahlen
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

7.  Bioflavonoids as poisons of human topoisomerase II alpha and II beta.

Authors:  Omari J Bandele; Neil Osheroff
Journal:  Biochemistry       Date:  2007-04-26       Impact factor: 3.162

8.  U-77,863: a novel cinnanamide isolated from Streptomyces griseoluteus that inhibits cancer invasion and metastasis.

Authors:  D R Welch; D E Harper; K H Yohem
Journal:  Clin Exp Metastasis       Date:  1993-03       Impact factor: 5.150

9.  Maize Lc transcription factor enhances biosynthesis of anthocyanins, distinct proanthocyanidins and phenylpropanoids in apple (Malus domestica Borkh.).

Authors:  Houhua Li; Henryk Flachowsky; Thilo C Fischer; Magda-Viola Hanke; Gert Forkmann; Dieter Treutter; Wilfried Schwab; Thomas Hoffmann; Iris Szankowski
Journal:  Planta       Date:  2007-07-06       Impact factor: 4.116

10.  QSAR study of p56(lck) protein tyrosine kinase inhibitory activity of flavonoid derivatives using MLR and GA-PLS.

Authors:  Afshin Fassihi; Razieh Sabet
Journal:  Int J Mol Sci       Date:  2008-09-22       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.